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Introduction
Nanoparticles (NPs) have the advantage of targeting cancer 
by simply being effectively accumulated and entrapped in 
tumors due to the phenomenon of enhanced permeability 
and retention caused by leaky tumor angiogenetic vessels 
and poor lymphatic drainage.1,2 This effect constitutes 
one of the major advantages of NPs against multiple 
drug resistance (MDR) mechanisms.3 Many of the drugs 
available to circumvent MDR were in the past unavailable 
to target this mechanism due to low solubility and/or 
stability. NPs made these drugs a possible strategy to target 
MDR. They have also provided an effective platform to 
deliver high loads of drugs in a specific and controlled 
way (using stimuli-sensitive and pH-responsive), with 
surface modified to improve circulation time, to prevent 
the uptake by the reticuloendothelial system and to ensure 
specific targeting (using bioactive agents like antibodies, 
receptor ligands, siRNA). Another advantage of using 
NPs for MDR regression is the drastic reduction of the 
IC50 value for drugs thus reducing the clinical doses. In 
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Abstract
Introduction: The aim of this research was 
to study the impact of various doxorubicin 
(Dox)-containing nanofluids, e.g. single-
walled carbon nanotube (SWCNT)+Dox, 
graphene oxide (GO)+Dox and Dextran-
PNIPAM (copolymer)+Dox mixtures on 
HeLa cells (human transformed cervix 
epithelial cells, as a model for cancer cells) 
depending on their concentration.
Methods: Structural analysis of GO+Dox complex was accomplished using Hartree-Fock level of 
theory in 6-31G** basis set in Gaussian. Dynamic light scattering (DLS), zeta-potential, scanning 
electron microscopy and confocal laser scanning microscopy were used. The cell viability was 
analyzed by the MTT assay.
Results: The viability of HeLa cells was studied with the MTT assay after the incubation with 
various Dox-containing dispersions depending on their concentration. The size of the particles was 
determined by DLS. The morphology of the nanoparticles (NPs) was studied by scanning electron 
microscopy and their uptake into cells was visualized by confocal laser scanning microscopy. It 
was found that the Dextran-PNIPAM+Dox nanofluid in contrast to Dox alone showed higher 
toxicity towards HeLa cells up to 80% after 24 hours of incubation, whereas the SWCNT+Dox and 
GO+Dox nanofluids at the same concentrations protected cells from Dox.
Conclusion: The importance of Dextran-PNIPAM copolymer as a universal platform for drug 
delivery was established, and the huge potential of Dextran-PNIPAM+Dox NPs as novel anticancer 
agents was noted. Based on the in vitro study of the SWCNT+Dox and GO+Dox nanofluids, it 
was concluded that SWCNT and GO NPs can be effective cytoprotectors against the highly toxic 
drugs.
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ratio (0.075:0.075 mg).
Structural calculations
The structural parameters of GO molecule were taken 
from14 and the initial structure was built with an aid of 
HyperChem8 software. After that, the structure of Dox 
molecule, taken from Protein Data Bank (PDB ID 1D12), 
was added in HyperChem. The planes of GO sheet and 
Dox chromophore were located parallel to each other at 
a distance of 3.4 Å which is typical of aromatic-aromatic 
stacking. The longitudinal axis of the Dox molecule was 
located above the central row of carbon cycles of the GO 
sheet. Preliminary optimization of this structure by means 
of molecular mechanics was performed in HyperChem 
using AMBER force field. After that full minimization by 
the energy of the spatial structure of GO+Dox complex 
was accomplished using Hartree-Fock level of theory in 
6-31G** basis set in Gaussian.
Dynamic light scattering and zeta potential 
determination
Measurements of size distribution and zeta potential for 
various aqueous mixtures containing different particles 
were performed by dynamic light scattering (DLS) on a 
Zetasizer Nano-ZS90 (Malvern, Worcestershire, UK) at 
T=298 K. The instrument was equipped with a He-Ne 
laser (5 mW) operating at the wavelength of 633 nm. The 
autocorrelation function of the scattered light intensity 
was analyzed by the Malvern Zetasizer software with the 
Smoluchowski approximation.
Scanning electron microscopy 
NPs presented in the studied samples were visualized 
by scanning electron microscopy (SEM) with an ESEM 
Quanta 400 instrument (FEI, The Netherlands) on gold/
palladium-sputtered samples.
Cell culture
HeLa cells were cultured in Dulbecco’s modified Eagle 
medium (DMEM), supplemented with 10% fetal calf 
serum (FCS), 100 U mL-1 penicillin, and 100 mg mL-1 
streptomycin at 37°C in humidified atmosphere with 5% 
CO2. 12 hours prior to the uptake experiments, the cells 
were trypsinized and seeded in 24-well plates with 5∙104 
cells per well in 0.5 mL DMEM with FCS for HeLa cells.
The cell line was obtained from the Collection of 
Microorganisms and Cell Cultures of the University of 
Duisburg-Essen.
Confocal laser scanning microscopy 
The uptake studies of NPs presented in the samples were 
carried out as follows: 30 μL of the nanofluid was added 
to the cells. The cells were incubated with the NPs for 3 
and 48 hours, respectively. Immediately after the indicated 
time, the cells were washed three times with phosphate-
buffered saline (PBS) in order to remove all dispersed NPs, 
fact, the lipid nanocapsules, polymeric micelles, metal 
and carbon NPs have been reported to circumvent drug 
resistance.4,5 In this regard, the conjugation of anticancer 
drugs, for example, doxorubicin (Dox) as a ‘gold standard’ 
of chemotherapy, with the representatives of carbon NPs 
could be promising for targeted drug delivery, overcoming 
of tumor cells drug resistance and reduction of side toxic 
effects.6-8
In the present work, we studied the impact of various 
Dox-containing nanofluids, e.g. single-walled carbon 
nanotube (SWCNT)+Dox, graphene oxide (GO)+Dox 
and Dextran-PNIPAM (copolymer)+Dox mixtures on 
HeLa cells (human transformed cervix epithelial cells, as a 
model for cancer cells) depending on their concentration.
Materials and Methods
Material preparation
Dox (Doxorubicin hydrochloride; Sigma-Aldrich, USA) 
was dissolved in saline with a maximum concentration of 
0.15 mg mL-1.
An aqueous solution of carboxylated SWCNT (Sigma-
Aldrich, USA) in a maximum concentration of 0.15 mg 
mL-1 was prepared as described in previously published 
papers.9,10
GO (Sigma-Aldrich, USA) was dispersed in ultrapure 
water to prepare a stock solution with a maximum 
concentration of 0.15 mg mL-1. Then this aqueous solution 
was sonicated for 2 hours (40 kHz).11
Preparation of the SWCNT+Dox and GO+Dox mixtures 
were executed according to the protocol: SWCNT or GO 
and Dox were mixed in a 1:1 volume ratio (0.075:0.075 
mg), and the resulting aqueous solution was treated in the 
ultrasonic disperser for 15 minutes, and after that stirred 
magnetically for 24 hours at room temperature.
The Dextran-PNIPAM copolymer used as a nanocarrier 
for Dox has been described in a recently published 
paper.12 This copolymer is star-like with Dextran 
core and PNIPAM grafts (Mw=1.03×106 g mol-1; Mw/
Mn=1.52; Dh=38 nm). Dextran-PNIPAM exhibits a lower 
critical solution temperature (LCST). The polymer is 
soluble in water below LCST and undergoes a phase 
transition above LCST becoming partially hydrophobic. 
The conformational transition for this copolymer was 
registered in the temperature range of 32.6-33.4°C, that 
higher than typical LCST point for linear PNIPAM of 
similar molecular weight and polydispersity and is closer 
to physiological temperature (37°C).13 A possible tuning 
of the hydrophobicity of star-like polymer, the regulation 
of the region of phase transition and size of hydrophobic 
domains by variation of copolymer internal structure was 
reported.12
A stock solution of Dextran-PNIPAM (0.15 mg mL-
1) was prepared in distilled water. This concentration 
is lower of a crossover concentration.13 For obtaining 
an aqueous solution of Dextran-PNIPAM+Dox, the 
Dextran-PNIPAM and Dox were mixed in a 1:1 volume 
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fixed with 4% paraformaldehyde at room temperature for 
10 minutes, then stained with fluorescent dye DAPI for the 
cell nucleus and washed three times with PBS. Finally, the 
cells were studied by confocal laser scanning microscopy 
(CLSM; analysis of z-stacks), which gave us information 
whether the NPs were able to enter the cells. CLSM was 
performed on a TCS SP8 AOBS system controlled by the 
LASX software (Leica Microsystems). The laser lines were 
used for the excitation by DPSS 561 nm (for Dox) and 
Diode 405 nm (DAPI). Images were acquired with a 20x 
objective. 
MTT assay
The cell viability was analyzed by the MTT assay 24 
and 48 hours after the incubation of cells with the 
NPs, so the final concentration of NPs per well after 
dilution in the medium was: 1.5, 3 and 6 µg mL-1. MTT 
(3-(4.5-dimethylthiazol-2-yl)-2.5-diphenyl-tetrazolium 
bromide; Sigma, Taufkirchen, Germany) was dissolved in 
PBS (5 mg/mL) and then diluted to 1 mg mL-1 in the cell 
culture medium. The cell culture medium of the incubated 
cells was replaced by 300 μL of the MTT solution. The 
cells were then incubated for 1 hour at 37°C under 
5% CO2 in a humidified atmosphere. About 300 μL of 
dimethyl sulfoxide (DMSO) was added to the cells. After 
30 min, a 100 μL aliquot was taken for spectrophotometric 
analysis with a Multiscan FC instrument (Thermo Fisher 
Scientific, Vantaa, Finland) at λ=570 nm. The absorption 
of incubated cells was normalized to that of control 
(untreated) cells, thereby indicating the relative level of 
cell viability.
Statistics
Statistical analysis was performed by conventional 
methods of variation statistics. The significance of 
the differences between the control and experimental 
measurements was estimated within the framework of 
the Student’s t-test using Origin 8.0 software (OriginLab 
Corporation, USA). The difference between the compared 
values was considered to be significant at P < 0.05.
Results and Discussion
Material characterization
The freshly prepared aqueous mixtures were characterized 
by DLS and SEM, in order to determine the aggregation 
state of NPs. Such information is considered important 
as the particles size is known to correlate with their 
bioactivity.15-19
Table 1 shows the experimental hydrodynamic sizes 
of various particles in aqueous solutions at 25°C. The 
Dextran-PNIPAM+Dox and SWCNT+Dox systems 
contain NPs with a hydrodynamic size of 69 to 81 nm. The 
GO+Dox mixture formed particles with hydrodynamic 
size 158 nm. The polydispersity index (PDI) falls in 
between 0.3-0.5 for all of the studied samples and indicates 
the degree of particle’s aggregation.
The zeta potential study has shown that at 25°C for the 
Dextran-PNIPAM+Dox, GO+Dox and SWCNT+Dox 
aqueous systems it takes values in between -9 and -13 
mV (see Table 1). A negative charge of the individual 
particles plays a significant role in the stabilization of the 
studied aqueous systems. It contributes to the electrostatic 
repulsion between the negatively charged clusters, thus 
disfavoring the aggregation and making the solution 
colloidally stable. For all studied systems, no signs of 
sediment and changes in UV-Vis absorption spectra were 
noted within the period of the experiment, suggesting the 
stability of the investigated mixtures.
Fig. 1 shows the SEM data for the studied samples, which 
provides additional confirmation of their polydispersity.
Structural analysis of the GO+Dox nanofluid was 
performed by means of a molecular modeling approach. 
It is known that both, GO and SWCNT, bind small 
aromatic molecules by formation of π-stacks with them in 
solution.6,20,21 The structure of the SWCNT+Dox complex 
is already known6 and was not investigated in this work. 
Hence, further analysis was focused on GO+Dox system.
It was initially assumed that the GO+Dox nanofluid 
contain GO+Dox complexes, which were studied by 
theoretical calculation of their spatial structures minimized 
by energy. Fig.2B contains the resultant structure of 1:1 
complex. As a consequence of the structure optimization, 
Table 1. The hydrodynamic diameter of particles (Z-average size), 
polydispersity index (PDI) and zeta potential for various aqueous 
systems at T=25°C
Sample Size (nm) PDI Zeta potential (mV)
Dextran-PNIPAM+Dox 69 0.36 -9
SWCNT+Dox 81 0.49 -13
GO+Dox 158 0.39 -10
Fig. 1. Scanning electron microscopy images of Dox (A), 
SWCNT+Dox (B), GO+Dox (C) and Dextran-PNIPAM+Dox (D).
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the initially flat sheet of GO has become bent accepting 
the shape of groove with the bending line passing over the 
central row of the carbon cycles (see dashed line in Fig. 
2A). Such bending of GO sheets is well known (e.g.).22 The 
optimized structure features the average distance between 
the carbon atoms of the Dox chromophore equal to 4.3 Å. 
The longitudinal axis of the Dox chromophore has shifted 
and located above the neighboring row of the carbon 
cycles (shown in Fig. 2A by the solid line). In general, as 
a consequence of energy minimization the stacking of 
GO and Dox molecules within the 1:1 complex has been 
preserved, although the resultant distance has appeared 
to be relatively high (~4.5 Å).23 In addition, the obtained 
geometry of the studied complex allows the formation of 
4 intermolecular hydrogen bonds between the GO and 
Dox molecules (see Fig. 2B), which, obviously, make a 
significant contribution to its stabilization. The possibility 
of intermolecular H-bonding within the π-stacked 
complexes of aromatic molecules including Dox is well 
known,24 and therefore, may be expected in GO+Dox 
nanofluid as well.
In vitro experiment
As can be seen from the Fig. 3A, Dox already kills about 
65% of cells for 24 h at the lowest used concentration of 
1.5 mg mL-1, and Dextran-PNIPAM+Dox almost 80% 
at the statistically significant level of difference. The 
effectiveness of these therapeutic drugs only increases 
(A)
(B)
Fig. 2. The structure of GO molecule (A) and the minimized structure 
of GО+Dox complex (B)
Fig. 3. MTT assay on HeLa cells after incubation with studied 
NPs at different concentrations for 24 hours (A) and 48 hours (B). 
*significant differences compared to the control (untreated cells) 
at P < 0.05.
with increasing concentration (Fig. 3A, B). As one can 
see, the Dextran-PNIPAM+Dox nanofluid shows a much 
higher toxicity towards HeLa cells in comparing with Dox 
alone.
At the same time, the SWCNT+Dox and GO+Dox 
nanofluids at the concentrations used are of low toxicity 
to cells, especially at the lowest concentration 1.5 mg mL-1 
(Fig. 3A, B), and also with increasing time of incubation 
time with the cells (Fig. 3B). Thus, it can be stated that 
the SWCNT and GO NPs protect cells from Dox. 
This observation can be explained using the following 
rationale. The results of the structural analysis performed 
above, as well as the literature data (e.g.6, 20, 21), suggest the 
complex formation of the SWCNT and GO NPs with Dox. 
We assume that this effect reduces the concentration of 
free Dox molecules able to induce cell death, thus leading 
to cell protection from the antibiotic action when Dox is 
administered together with NPs, as compared with the 
Dox action as a single agent. The mechanism described is 
well known in literature with respect to small molecules, 
called as ‘interceptors’ or ‘scavengers’, which can bind with 
Dox via π-stacking (see 24,25 for details), and has recently 
been revealed for Dox binding with another carbon 
nanoparticle, i.e. C60 fullerene.7,8 Most likely, the molecular 
complexations act here as the universal physicochemical 
factor, which is independent of the type of biosystem 
under study.
Finally, the Dox, Dextran-PNIPAM+Dox, SWCNT+Dox 
and GO+Dox NPs demonstrated even more pronounced 
treatment and protective effects (about 80-90% cells in 
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both cases), respectively, when incubated with the cells for 
48 hours (Fig. 3B).
It should be noted that SWCNT, GO and Dextran-
PNIPAM NPs are non-toxic in vitro and in vivo in the 
concentration range under study (up to 6 mg mL-1).26-28 
It is known that Dox-induced toxicity and resistance 
are major obstacles in chemotherapeutic approaches. The 
mechanisms of toxicity and resistance are respectively 
related to induction of reactive oxygen species and up-
regulation of ATP-binding cassette transporter.29 Thus, 
one can assume that coadministration of SWCNT and GO 
NPs with a high Dox dose is capable of ameliorating its 
cytotoxicity through their antioxidant potential.15,26,28,30,31
It is important to emphasize that the Dextran-
PNIPAM copolymer is thermosensitive with a transition 
temperature from the hydrophilic to the hydrophobic 
state of the macromolecule in the region of physiological 
temperatures.12 Therefore, one can assume that the 
anticancer activity of Dextran-PNIPAM+Dox nanofluid 
sharply increases due to a change in the conformation 
of the Dextran-PNIPAM copolymer, which promotes 
the release of Dox molecules. Thus, the novel Dextran-
PNIPAM copolymer can be used as a potential carrier 
of anticancer drugs (for example, Dox) as opposed to 
SWCNT and GO NPs. As shown above, both GO and 
SWCNT act as interceptors of Dox molecules due to the 
formation of GO+Dox and SWCNT+Dox complexes, thus 
reducing the concentration of monomeric Dox molecules 
able to induce cell death.
The in vitro uptake of NPs by HeLa cells was studied 
by CLSM. For this purpose, we used Dox as a fluorescing 
marker (~500 nm; Dox gives a red fluorescence).31,32 
Fig. 4 shows the cellular uptake and the distribution 
of SWCNT+Dox (A) and GO+Dox (B) after 48 h of 
incubation on HeLa cells. NPs were thoroughly washed in 
all these cases to remove adhering or dispersed NPs. Fig. 
5 demonstrates the z-stack through the cells, which were 
carried out to prove the accumulation of GO+Dox inside 
the cells and not on their surface. It is important to note 
that in the case of Dextran-PNIPAM+Dox NPs, the results 
for CLSM almost are no different from those we obtained 
earlier for pure Dox at 3 hours of incubation with HeLa 
cells.33 This again confirms the fact that the water-soluble 
Dextran-PNIPAM copolymer acts as the Dox molecules 
transporter into cells, actively releasing them to the 
intracellular space at physiological temperature.12 Thus, 
one may conclude that the Dextran-PNIPAM+Dox NPs 
can be used for further pre-clinical trials.
Conclusion
This study clearly demonstrates that water-soluble 
Dextran-PNIPAM+Dox NPs sharply decreased the 
viability of HeLa cells at the low concentrations (1.5-
6 µg mL-1) for 24-48 hours. This result indicates on 
the importance of Dextran-PNIPAM copolymer as a 
universal platform for drug delivery, and, in particular, the 
huge potential of Dextran-PNIPAM+Dox NPs as novel 
anticancer agents.
Fig. 5. Analysis of z-stacks carried out by laser confocal scanning 
microscopy on HeLa cells after incubation with GO+Dox (B; 48 h; 
6 μg mL-1) NPs. This information could prove, that NPs were able 
to go inside a cell.
Fig. 4. Laser scanning confocal microscopy images of HeLa cells after incubation with SWCNT+Dox (A, time of incubation 48 h; 
concentration 6 μg mL-1) and GO+Dox (B; 48 h; 6 μg mL-1) NPs. 
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At the same time, the SWCNT+Dox and GO+Dox 
nanofluids are of low toxicity to HeLa cells at the same 
conditions, and hence, the SWCNTs and GO NPs can 
be effective cytoprotectors against the high toxic drugs. 
Moreover, the SWCNTs, as well as GO NPs, offer a 
great potential for upcoming nanomedicines nanoscaled 
devices, including biosensor and bioimaging techniques.
Finally, the uptake of the NPs into cancer cells was 
shown by CLSM.
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